Cargando…
H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
MLL gene rearrangements (MLLr) are a common cause of aggressive, incurable acute lymphoblastic leukemias (ALL) in infants and children, most of which originate in utero. The most common MLLr produces an MLL-AF4 fusion protein. MLL-AF4 promotes leukemogenesis by activating key target genes, mainly th...
Autores principales: | Godfrey, Laura, Crump, Nicholas T., O’Byrne, Sorcha, Lau, I-Jun, Rice, Siobhan, Harman, Joe R., Jackson, Thomas, Elliott, Natalina, Buck, Gemma, Connor, Christopher, Thorne, Ross, Knapp, David J. H. F., Heidenreich, Olaf, Vyas, Paresh, Menendez, Pablo, Inglott, Sarah, Ancliff, Philip, Geng, Huimin, Roberts, Irene, Roy, Anindita, Milne, Thomas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787973/ https://www.ncbi.nlm.nih.gov/pubmed/32242051 http://dx.doi.org/10.1038/s41375-020-0808-y |
Ejemplares similares
-
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
por: Rice, Siobhan, et al.
Publicado: (2021) -
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
por: Kerry, Jon, et al.
Publicado: (2017) -
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
por: Crump, Nicholas T., et al.
Publicado: (2023) -
DOT1L inhibition reveals a distinct subset of enhancers dependent on H3K79 methylation
por: Godfrey, Laura, et al.
Publicado: (2019) -
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
por: Castaño, Julio, et al.
Publicado: (2016)